UC San Diego physicists are discovering details about the fundamental properties of exotic particles known as excitons. Their findings include pinpointing a visual phenomenon tied to a new state of matter as well as the first confirmation of exciton superfluidity.
The Qualcomm Institute at the University of California San Diego has appointed the composer, music professor and sound designer Shahrokh Yadegari to be an Associate Director of the interdisciplinary institute.
UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.
Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
It’s been more than a year since our news feeds first alerted us to a mysterious illness and its rapid spread. Since then, the COVID-19 pandemic has transformed our lives and touched every part of the globe.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
